Pronóstico del mercado del genoma digital de América del Norte hasta 2027: impacto de COVID-19 y análisis regional por producto (análisis de ADN/ARN, chips de secuenciación, instrumentos analizadores y de secuenciación, instrumentos de preparación de muestras, software de análisis y secuenciación); Aplicación (Diagnóstico, Agricultura, Investigación académica, Descubrimiento de fármacos, Personalización de la medicina, Otras aplicaciones); Usuario final (laboratorios de diagnóstico y forense, institutos de investigación académica, hospitales, otros usuarios finales) y país
Introducción al mercado
El genoma digital es una disposición digital avanzada y completa de material genético que se produce en una célula o en un organismo. Es una forma más sencilla de acumular información sobre enfermedades crónicas y utilizada por expertos para obtener una mejor visión de los trastornos genéticos. La genómica digital se ocupa de genes y sus funciones y tiene como objetivo identificar y abordar los factores detrás de los trastornos crónicos para resolverlos. Esta tecnología ha provocado una revuelta en la investigación y el desarrollo centrados en la invención. biología de sistemas para acelerar el conocimiento de los sistemas genéticos más complejos.
Descripción general y dinámica del mercado
El mercado del genoma digital de América del Norte alcanzará los 9.594,71 millones de dólares en 2027, frente a los 4.999,94 millones de dólares de 2019. Se prevé que el mercado crecerá a una tasa compuesta anual del 8,7 % entre 2019 y 2027. Factores como la Se espera que la creciente prevalencia de enfermedades crónicas y la creciente financiación para la genómica impulsen el crecimiento del mercado del genoma digital. Sin embargo, es probable que el mercado se vea afectado por factores de riesgo como la seguridad y la confidencialidad de los datos del paciente durante el período de pronóstico.
Segmentos clave del mercado
En términos de producto, el segmento de instrumentos analizadores y de secuenciación representó la mayor participación del mercado del genoma digital de América del Norte en 2019. El segmento de laboratorios forenses y de diagnóstico representó la mayor parte participación del mercado del genoma digital de América del Norte, por usuario final, en 2019. En términos de aplicación, el segmento de diagnóstico representó la mayor participación del mercado del genoma digital de América del Norte en 2019.
Principales fuentes y empresas enumeradas
Varias fuentes primarias y secundarias importantes asociadas con el informe del mercado del genoma digital de América del Norte son los centros de la Organización Mundial de la Salud (OMS). de Control y Prevención de Enfermedades (CDC), Federación Internacional de Diabetes (FID), Instituto Nacional de Investigación del Genoma Humano (NHGRI), Estadísticas de Salud de la OCDE y otros.
Razones para comprar informe
- Proporciona comprensión del panorama del mercado del genoma digital en América del Norte e identifica los segmentos del mercado del genoma digital que tienen más probabilidades de garantizar un fuerte retorno.
- span>
- Guía para mantenerse a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado del genoma digital de América del Norte.
- Ayuda planificar de manera eficiente fusiones, adquisiciones y acuerdos de asociación en el mercado del genoma digital mediante la identificación de segmentos de mercado con las ventas probables más prometedoras
- Facilita la toma de decisiones comerciales informadas a través de un análisis perceptivo e integral de lo digital Rendimiento del mercado del genoma de varios segmentos pertenecientes al mercado del genoma digital de América del Norte.
- Proporciona un pronóstico de ingresos del mercado del genoma digital basado en varios segmentos para el período de 2019 a 2027.
SEGMENTACIÓN DEL MERCADO DEL GENOMA DIGITAL DE AMÉRICA DEL NORTE
Por producto
- Instrumentos analizadores y de secuenciación
- Análisis de ADN/ARN
- Software de secuenciación y análisis
- Chips de secuenciación
- Instrumentos de preparación de muestras
Por aplicación
- Diagnóstico
- Descubrimiento de fármacos
- Investigación académica
- Medicina personalizada
- Agricola
- Otro
Por usuario final
- Laboratorios de diagnóstico y forense
- Institutos de investigación académica
- Hospitales
- Otro
Por país
- Estados Unidos
- Canadá
- México
Perfiles de la empresa
- BD
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- GenomeMe
- NanoString Technologies, Inc,
- GenMark Diagnostics, Inc
- Perkin Elmer, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Digital Genome Market – By Product
1.3.2 North America Digital Genome Market – By Application
1.3.3 North America Digital Genome Market– By End User
1.3.4 North America Digital Genome Market – By Country
2. North America Digital Genome Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Digital Genome Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Digital Genome Market - North America PEST Analysis
4.3 Expert Opinion
5. North America Digital Genome Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Funding for Genomics
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Key Market Restraints
5.2.1 Security and Confidentiality Issue
5.3 Key Market Opportunities
5.3.1 Increasing Technological Advancement in Digital Genome Field
5.4 Future Trends
5.4.1 Increasing Demand for Personalized Medicines
5.5 Impact Analysis
6. Digital Genome Market – North America Analysis
6.1 North America Digital Genome Market Revenue Forecasts and Analysis
7. North America Digital Genome Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 North America Digital Genome Market, By Product 2019 & 2027 (%)
7.2.1 North America Digital Genome Market Revenue and Forecasts to 2027, By Product (US$ Mn)
7.3 DNA/RNA Analysis
7.3.1 Overview
7.3.2 North America DNA/RNA Analysis Market Revenue and Forecast to 2027 (US$ Mn)
7.4 Sequencing and Analyzer Instruments
7.4.1 Overview
7.4.1.1 North America Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
7.5 Sequencing and Analysis Software
7.5.1 Overview
7.5.2 North America Sequencing and Analysis Software Market Revenue and Forecast to 2027 (US$ Mn)
7.6 Sequencing Chips
7.6.1 Overview
7.6.2 North America Sequencing Chips Market Revenue and Forecast to 2027 (US$ Mn)
7.7 Sample Prep Instruments
7.7.1 Overview
7.7.2 North America Sample Prep Instruments Market Revenue and Forecast to 2027 (US$ Mn)
8. North America Digital Genome Market Analysis and Forecasts To 2027 – By Application
8.1 Overview
8.2 North America Digital Genome Market, By Application 2019 & 2027 (%)
8.2.1 North America Digital genome Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Diagnostics
8.3.1 Overview
8.3.2 North America Diagnostics Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Drug Discovery
8.4.1 Overview
8.4.2 North America Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Academic Research
8.5.1 Overview
8.5.2 North America Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Personalized Medicine
8.6.1 Overview
8.6.2 North America Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Agricultural
8.7.1 Overview
8.7.2 North America Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Others
8.8.1 Overview
8.8.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
9. North America Digital Genome Market Analysis – By End-User
9.1 Overview
9.2 North America Digital Genome Market, By End-User 2019-2027 (%)
9.2.1 North America Digital Genome Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
9.3 Diagnostics and Forensic Labs
9.3.1 Overview
9.3.2 North America Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
9.4 Academic Research Institutes
9.4.1 Overview
9.4.2 North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Hospitals
9.5.1 Overview
9.5.2 North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
10. Digital genome Market Revenue and Forecasts To 2027 – Geographical Analysis
10.1 North America Digital genome Market Revenue and Forecasts To 2027
10.1.1 Overview
10.1.2 North America: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.3 North America: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.4 North America: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.5 North America: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.6 North America: Digital Genome Market, by Country, 2019 & 2027 (%)
10.1.7 US: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.1 US: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.7.2 US: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.7.3 US: Digital Genome Market, by Application, 2018–2027 (USD Million)
10.1.7.4 US: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.8 Canada: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.1 Canada: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.8.2 Canada: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.8.3 Canada: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.8.4 Canada: Digital Genome Market, by End User , 2018–2027 (USD Million)
10.1.9 Mexico: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.1 Mexico: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
10.1.9.2 Mexico: Digital Genome Market, by Product, 2018–2027 (USD Million)
10.1.9.3 Mexico: Digital Genome Market, by Application , 2018–2027 (USD Million)
10.1.9.4 Mexico: Digital Genome Market, by End User , 2018–2027 (USD Million)
11. Impact of COVID-19 Pandemic on North America Digital Genome Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Company Profiles
12.1 THERMO FISHER SCIENTIFIC INC
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Illumina, Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 GenomeMe
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 NanoString Technologies, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 BD
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 GenMark Diagnostics, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Perkin Elmer, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Digital Genome Market Revenue and Forecasts To 2027, By Product (US$ Mn)
Table 2. North America Digital genome Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. North America Digital Genome Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 4. North America Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 5. North America Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 6. North America Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 7. US Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. US Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 9. US Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Digital Genome Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Digital Genome Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Digital Genome Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 16. Glossary of Terms, Digital Genome Market
LIST OF FIGURES
Figure 1. Digital Genome Market Segmentation
Figure 2. North America Digital Genome Market Overview
Figure 3. The Sequencing and Analyzer Instruments Segment Held Largest Share of Digital Genome Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. North America Digital Genome Market - Leading Country Markets (US$ Mn)
Figure 6. Digital Genome Market - North America PEST Analysis
Figure 7. Digital Genome Market Impact Analysis of Driver and Restraints
Figure 8. North America Digital Genome Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 9. North America Digital Genome Market, By Product 2019 & 2027 (%)
Figure 10. North America DNA/RNA Analysis Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. North America Sequencing and Analyzer Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. North America Sequencing and Analysis Software Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 13. North America Sequencing Chips Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. North America Sample Prep Instruments Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. North America Digital Genome Market, By Application 2019 & 2027 (%)
Figure 16. North America Diagnostics Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. North America Drug Discovery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. North America Academic Research Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. North America Personalized Medicine Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. North America Agricultural Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 22. North America Digital Genome Market, by End-User 2019 & 2027 (%)
Figure 23. North America Diagnostics and Forensic Labs Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. North America Academic Research Institutes Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. North America Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. North America Others Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. North America: Digital Genome Market, by Key Country – Revenue (2019) (USD Million)
Figure 28. North America Digital Genome Market Revenue and Forecast to 2027 (USD Million)
Figure 29. North America: Digital Genome Market, by Country, 2019 & 2027 (%)
Figure 30. US: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 31. Canada: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Mexico: Digital Genome Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in North American Country Markets
The List of Companies - North America Digital Genome Market
- BD
- THERMO FISHER SCIENTIFIC INC
- Illumina, Inc
- GenomeMe
- NanoString Technologies, Inc,
- GenMark Diagnostics, Inc
- Perkin Elmer, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America digital genome market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America digital genomemarket, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.